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The main goal of this study is the quantification of the particle transport and
deposition within the human airways during light, normal and exercise
breathing conditions using the computational fluid dynamics. In particular we
presented a comparison between healthy and stented airways. The considered
tracheobronchial model is based on the Weibel symmetric model in which we
have inserted the Dumon prosthesis at different locations and on the CT-
based geometries of a healthy and a stented airway. The results indicate an
important redistribution of the particle deposition locations. Local overdoses
can be found in the proximal regions of the prostheses, independently of the
breathing conditions, of the particle size and of the considered geometry. The
presented work is aimed to contribute to the understanding of the particle
deposition in the human lung and to improve drug-aerosol therapies. For
patients that underwent airways reconstructive surgery, it can give detailed
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Introduction
Aerosol drug therapy mainly consists in delivering the drug in the human
respiratory system. Drug inhaled through the mouth should theoretically reach
specific regions within the tracheobronchial tree such as large and/or small
airways conducts. Unfortunately, even though inhalers devices are designed for
delivering the aerosol particles maximizing their deposition, the latter takes
place in variable regions of the respiratory tract, mainly in the upper airways.14
This non-optimal distribution finally results in undesirable and dangerous side
effects for the patient apart of a non-useful depositions and a drug waste. It is
known that the transport, the magnitude and the location of particle deposition
within the human airways depend on the aerosol particle size and the breathing
flow rate.14,20,24 Since detailed information within bifurcating airways is
difficult to be obtained experimentally, in recent years, the computational fluid
dynamics (CFD) has been used for analysing and providing such knowledge as
a function of variable breathing conditions. A wide range of micro and nano
particles has been numerically simulated in symmetric and asymmetric
idealized trees for computing particle trajectories. Straight tubes based on the
human airways anatomy has been used for evaluating particle transport and
deposition by Refs. 3, 4, 16, 28 and 29. Nevertheless, other works have studied
patient specific geometries of human lung including a variable number of
tracheobronchial tree generations.12,19,20,23,24 Recent advanced in this field
have been focused on the comparison between idealized and realistic or patient
specific data of the human airways.22,23 These studies have shown substantial
differences between a realistic geometry and a simplified one concluding that
the particle deposition and transport is more accurately predicted by realistic
geometries. In spite of these findings, idealized Weibel models27 are still used
for giving a first insight or some qualitative results on particle transport and
depositions.4–6 Despite the knowledge on the computation of particle transport
and deposition acquired for healthy subjects, less interest has been given to the
deposition of particles in case of obstruction that have been analyzed only in
few studies.10,17,30 Chen et al.2–4 provide a comprehensive study in this
sense, using a Weibel-based model. However, the mechanism of lung injury due
the to particles inhalation and deposition is still the object of the study. Hence, a
detailed analysis of micro particle transport phenomena in the human airways is
needed for a better understanding of the fluid-particle dynamics, and for
providing more useful information for health risk assessment and/or drug
aerosol therapy improvements. This is especially important for patients with
pulmonary diseased and patient that underwent surgical reconstruction or
intervention of the airways. Chronic obstructive pulmonary disease (COPD)
incidence is estimated around 10% in adult patients.1 Chronic bronchitis and
emphysema are the main affections although there are many diseases that lead
to airway obstruction. They all promote increased airflow resistance due to
airway inflammation, edema and mucus retention.
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The airways stents solve the acute obstruction but they modify the inner lumen
of the airway and hence the airflow.17 However, they have several
contraindications. The implantation of a device promotes inflammations and
tissue reactions among others negative effects.8 Therefore, it is clear that local
concentration of particles inhaled from the atmosphere or local overdoses of
aerosol or other drugs may enhance these situations and further knowledge is
necessary for improving eventual therapies and the overall clinical outcomes.
As far as the authors know, although in the literature there are a few studies that
report particle depositions in case of constricted or obstructed airways,2,10,30
the potential benefits of inhaled therapy in patients with airway stents has not
been studied.
The present work is oriented to the characterization of the particle transport and
deposition of healthy idealized and CT-based respiratory tract in comparison
with stented airways. The idealized models allow analyzing different situations
(or different stents) while patient specific models provide more precise
depositions in real configurations. A systematic analysis is presented with the
aim of providing a detailed understanding of particle regional distribution in the
airways of patients that underwent surgical prosthesis implantation.
Materials and Methods
Geometry: Idealized airways model
The particle deposition was studied in a double bifurcating model with
generations GEN0-GEN1 and GEN0-GEN2 respectively.16 Its dimensions are
similar to those of Weibel symmetric model27 with a branching angle  for
each bifurcation. In particular, the diameters of the generation 0, 1 and 2 are
1.8, 1.2 and 0.8 cm respectively while the corresponding length are 12, 4.5 and
1.9 cm. For sake of simplicity, the effects of out-of-plane bifurcations have not
been considered in the present analysis.4, 5,28 The idealized airways model has
been created by means of the commercial package Rhinoceros  (Robert
McNeel and Associates, Seattle, WA, USA) and consisted of a series of straight
vessel tubes. The model includes the trachea down to the GEN2 and it is
represented in Fig. 1a along with a zonal subdivision of the geometry. Finally,
the inlet and outlet regions have been sufficiently extended for damping the
effect of the imposition of the boundary conditions such as plugged inflow and
backflow effects.26 After a sensitivity analysis performed on the healthy
Weibel-based model, we found that a length of 5 diameters is sufficient for this
scope. The extensions allow fully developed flow on the idealized model.
However, the flow is not necessarily fully developed in the reality due to the
presence of the nasal regions, the larynx and other geometrical changes
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affecting the trachea and the asymmetric bifurcations. As the Weibel model is
idealized and it is made of a repetitive successions of perfect tubes, the flow can
actually develop, at least in the trachea. In this sense, and for comparison
purpose within Weibel-based models, the fully developed flow as boundary
conditions for their analysis can be justified.
Figure 1
Idealized Weibel-based (a) and patient specific airways geometries (b) healthy
and (c) stented respectively) with close-up view to the grid resolutions at the inlet
and at the bifurcation. The used Dumon stents are included beside each model.
The zonal division in both cases is represented by different colors.
Figure 2
Comparison between the velocity streamlines of the healthy and stented airways
at steady inhalation (30 L/min). In each case, axial velocity contours depicted on
selected airways cross sections are shown.
Using the Weibel-based geometry, three different prostheses have been inserted
in the trachea, in one of the main bronchi and in the carina. In particular we
have considered the Dumon stent, i.e. a tracheal, a bronchial and a carina Y




Main dimensions of the considered silicone Dumon endoprostheses.8
Thickness [mm] Length [mm] Inner diameter [mm]
Tracheal stent 1 40 16
Bronchial stent 1 30 10
Y stent 1 40/30/30 15/10/10
The three dimensions given for the Y stent refer to the three segments of the
device Why this sentence is placed at the boom of the Table? Please note that it is a part of
the Table caption and shoul be placed at the top:
Table 1
Main dimensions of the considered silicone Dumon endoprostheses . The three dimensions given
for the Y stent refer to the three segments of the device.
Figure 3
Comparison of the computational results of the present Weibel- and CT-based
model with the numerical findings of Nowak et al.19 (a) and with the predictions
of the in vitro model of Martonen et al.18 (b). The comparison was performed
using laminar and turbulent flow rate of 28.3 L/min and 45 L/min respectively
along the generations GEN 0, GEN 1 and GEN 2 of the model depicted in Fig. 1.
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Geometry: CT-Based Model
While the Weibel model allows introducing different types of prosthesis, the
patient specific models require additional work related to the images
segmentation but they provide more precise information.23 The patient specific
geometries were extracted from computerized tomography (CT) images of two
healthy adult subjects, one healthy and one in the presence of a Dumon tracheal
prosthesis. The DICOM files were imported in the commercial software
package MIMICS  (Materialise, Leuven, Belgium). A semi-automatic
segmentation was carried out in order to generate the three-dimensional models
that were exported as stereolithography (STL) file. Finally, the Weibel-based
and the CT-based healthy model were used at selected flow conditions for
validating the overall methodology. In particular, a comparison with numerical
and experimental literature data was carried out.18,19
©
Figure 4
3D histograms of the deposition fraction of different zones for two particle
diameters ( ) and two different breathing conditions along the healthy and the
stented geometries: (a) m, flow rate = 15 L/min, (b) m,
flow rate = 15 L/min, (c) m, flow rate = 30 L/min and (d) 
m, flow rate = 30 L/min.
Figure 5
3D histograms representing the regional deposition fractions for particle diameter
of 15, 10, 5 and m and inspiratory flow rate of 15, 30 and 60 L/min.
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Numerical Modeling and Boundary Conditions
Unstructured tetrahedral computational grids were generated using the
commercial software Ansys ICEM CFD, Version 16.0 (ANSYS Inc.,
Canonsburg, Pennsylvania). To ensure independent results from the mesh
element size, a mesh independency study was carried out. In particular, we
considered as converged a mesh providing velocity profiles within  from the
finest tested mesh.4 We tested four different grids of 0.75 millions, 1.5 millions,
3 millions and 6 millions elements. Convergence was reached with the grid size
of 1.5 millions elements (see Fig. 1). To fully capture the turbulent boundary
layer profile at the near wall regions, the mesh structure includes 5 prism layers
at the geometry surface. Considering the turbulence model used in this study,
the  value for the mesh refinement used was less than 1. This value is
sufficiently small for resolving the near-wall turbulent fluid dynamics.24 Steady
conditions are assumed for the airflow.12,15,23,24 CFD simulations were
carried out using the commercial software Ansys Fluent, Version 16.0 (Ansys
Inc., Canonsburg, Pennsylvania). This software is well known in the scientific
community for solving such problems and details of the software methodology,
algorithms and other information are given in the Ansys documentation. The
solution of the flow field was assumed as converged when the scaled residuals




the field of the analysis of particle deposition and transport in human upper
airways.21–24,30 The material (air) was assumed to be an incompressible and
Newtonian fluid (  kg/m ,  kg/(m  s)). The airways
walls were assumed to be rigid with a no-slip boundary condition. Constant
flow rates of 15 L/min, 30 L/min and 60 L/min that corresponds to light, normal
and heavy breathing conditions respectively,18,24,28 were imposed at the inlet
of the CT-models. For the Weibel models, that are simulated as a proof of
concept, constant flow rates of 15 L/min, 30 L/min are adopted. At each outlet a
0 Pa pressure condition24 was imposed. The used mass flow rates and the
corresponding inlet velocities are summarized in the Table 2. For validation
purpose, the healthy Weibel-based model was simulated with a laminar flow
rate of 28.3 L/min that was used by Nowak et al.20 and with a turbulent flow
rate of 45 L/min that were used by Martonen et al.18 For the pressure-velocity
coupling, we used the SIMPLEC algorithm offered by Ansys Fluent. The
different terms of the transport equations were discretized using the second-
order upwind numerical scheme. As turbulent model, the  SST model was
used.14,23,24,28
Table 2
Characteristics of different breathing conditions.
Light breathing Normal breathing Heavy breathing
Flow rate [L/min] 15 30 60
Inlet velocity [m/s] 0.9825 1.965 3.93
Figure 6
Total deposition fraction for different flow rates and different particle diameters
along the Weibel-based and the CT-based healthy and stented airways.
$ = 1.225 3 " = 1.83 ⋅ 10−5 ⋅
% − &
Figure 7
Variation of the deposition patterns (in [ g/cm  s]) for different particle sizes at
light breathing conditions (15 L/min).
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Figure 8
Variation of the deposition patterns (in [ g/cm  s]) for a fixed particle diameter
of m as a function of different inspiratory flow rate of 15 L/min (a),





The commercial software Ansys Fluent offers several applications using the
discrete phase model (DPM) as the aerosol transport and deposition considered
in this study. The particle tracking is performed in a Lagrangian reference frame
that is applicable for a low volume fraction of the dispersed particle phase. In
this reference, each particle are individually followed defining its initial
position, velocity, size and temperature. The computation of the trajectories is
based on a force balance, using the local continuous phase conditions as the
particle moves through the flow. This is performed integrating the force balance
that can be expressed as follows:





where  is the particle velocity and F is the force term which includes
several terms. However, due to the small value of particle Reynolds number (
), the large value of fluid-particle density ratio ( ) and the size
of the considered particles, most of this terms can be neglected.22 In the present
study, we used only the contribution of the drag and of the gravitational force.
The equation describing the particle velocity, in the Lagrange formulation, for a
Cartesian coordinate system can be written in the form:
where u is the fluid velocity,  is the particle diameter. The term 
is the drag force per unit particle mass and  can be computed as:
where  is the drag coefficient,  is the dynamic viscosity of the fluid and 
 is the particle Reynolds number that involves its relative velocity with the
fluid. The drag coefficient and the relative Reynolds number are computed as
follows:
where ,  are constants.23,24
Particles of specific sizes were injected in a uniform distribution at the inlet
face of the computation domain, and tracked through the geometry until they
found one of the three specific conditions: they collide and are trapped on the
airways walls, they escape from the domain through one of the outlet faces or
they continue suspension in the flow. The present work considers two-way
coupling between airflow and particle motion. The latter means that the fluid
(continuous phase) and the particles motion (discrete phase) are mutually
affected by each other. However, since the particles size is sufficiently small
and the suspension is dilute, the effect of the particles on the airflow is actually
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negligible. The continuous phase was performed previous to the discrete phase.
Particles were considered as spherical, with a density of  kg/m , a
diameter of m and a velocity equal to that of the model
inlet.24 These particular particle diameters have been chosen for simulating the
typical micro particle that characterize the aerosol. For ensuring that the results
were independent on the number of injected particle, a sensitivity study for the
particles was carried out. After the analysis, over 11,000 particles for each size
were injected through the inlet of each considered model.
Results
Flow Patterns of the Healthy and Stented Model
Weibel-Based Model
In this section, the main features of the airflow for the healthy and the stented
airways are presented for giving an overview of the device influences on the
flow patterns. This comparison is qualitatively given for the flow rate 30 L/min
but it is valid also for the flow rate 15 L/min. The velocity magnitude, of course
increases by increased inspiratory flow rates and secondary flows vortices tend
to become larger.
In the Fig. 2, the flow patterns for the healthy airways are shown by means of
three-dimensional streamlines and planar contours of velocity magnitude.
Comparing the healthy and the stented airways, considerable differences can be
seen. In particular, the presence of the device promotes in all the considered
cases a variation of the local flow patterns. For the healthy case (Fig. 2a), as
expected, at the carina, the flow divides and a secondary velocity field develops
into the main bronchi. Secondary flows develop also at the second flow divider.
The tracheal device, on the contrary, not only changes the velocity patterns at
the trachea but also influences the flow regime downstream, in the lower
generations (Fig. 2b). This aspect is also enhanced in the airways model in the
presence of the bronchial device (Fig. 2c). While a local acceleration is
promoted in the bronchus where the device is located, the flow seems to be
altered also in the other bronchus and in the lower generations, compared with
the healthy airways. Finally, the Y stent seems to be the most impacting device
(Fig. 2d). The flow patterns are in fact altered at the trachea and in both main
bronchi, where the device is located. The presence of the device promotes a
local acceleration and deceleration of the flow and also a change of the intensity
of the secondary flow structures that develop inside the generations GEN1 and
= 1000${p} 3
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GEN2.
CT-Based Model
The results found in the Weibel based geometries allow extracting qualitatively
similar conclusions to what can be found for the CT-models. However,
quantitative differences can be seen. In the Fig. 2 (lower panel), it is shown that
secondary flows develop into the main bronchi for both healthy and stented
geometries. Moreover, the prosthesis markedly impacts the tracheal flow due to
the reduction of the lumen promoted by its introduction. The impact is not
limited to the first generation but it is also extended to the successive
generations after the carina as for the Weibel model. Interestingly, it can be seen
an important asymmetric distribution of the flow especially enhanced for the
stented model respect to the healthy case (compare Figs. 2e and 2f). This is due
to the slightly higher asymmetry of stented geometry respect to the healthy
model. Additionally, it is visible that the airflow enters the device skewed, as
the asymmetry regards not only the bifurcation but also the tracheal tract. This
is visible comparing for example the Weibel-based tracheal stented model with
the CT-based geometry in the presence of the device. The flow enters the device
with a higher velocity and with a skewed direction as its tracheal axis is not
straight. Both aspects are important because they have a massive influence on
the particle deposition. Also at the bifurcation, the high asymmetry promotes
higher airflow velocity in the primary branches and the flow distribution is very
asymmetric. A comparison with the Weibel models (see Figs. 2b and 2f) allows
seeing that the asymmetry of the airflow regards also the second bifurcation and
promotes considerably different velocity patterns in these regions. The Fig. 2f)
shows in fact markedly different flow regimes at the second bifurcation
comparing both branches. The latter cannot be found neither in the healthy CT-
based model (Fig. 2e) nor in the Weibel stented models of the Figs. 2a–2c. All
these geometrical and morphological aspects confirms the importance of
considering patient specific models for computing more precisely the airflow
and, as a consequence, the particle transport and deposition.
Benchmarking Present Study Results with Literature Data
Regional particle deposition obtained in the current work was compared to the
numerical results reported by Nowak et al.19 and by Martonen et al.18 obtained
using the Weibel-based model. Firstly, the Weibel-based healthy model has been
compared with that of Nowak et al. for a particle size of m, an inhalation
flow rate of 28.3 L/min and a laminar flow (see Fig. 3a). Then, the Weibel-
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5
based model and the CT-based airways have been compared with the model of
Martonen et al. for a particle size of m, an inhalation flow rates of
45 L/min and a turbulent flow (see Fig. 3b). The deposition fraction accordingly
to Zhang et al.28 is computed as:
With aim of identifying the regional deposition of particles, the airway
geometry was segmented into 7 zones according to Fig. 1a. The local deposition
fraction in each zone was calculated and plotted for the present models and the
aforementioned literature studies.
The comparison performed on the three main generations (GEN 0, GEN 1 and
GEN 2 of Fig. 3a shows a good agreement. The main difference regards the
particle trapped in the trachea that are zero in the work of Nowak et al.19 while
are of about  in the present work (see Fig. 3a). This difference is
probably due to the different grid resolution and to the different number of
generations considered in these two works.
In the Fig. 3b, the deposition of m particle of the turbulent simulations for
the Weibel- and CT-based airways models is compared in the aforementioned 3
generations GEN 0, GEN 1 and GEN 2 with the findings of Martonen et al.18
From this comparison it appears that the deposition obtained in the present CFD
simulations and those obtained by Martonen et al. are of the same order. In
particular, it seems that the prediction is more accurately provided in the trachea
(see Fig. 3b) while in the following generations differences appear. These can
be explained considering the different approach used in these studies and the
overall different geometrical model. In general, the computational results seem
to slightly underestimate the results of Martonen, as the difference of  at the
first generation tends to increase in second and in the third generation. In
particular, as depicted in the Fig. 3b, the Weibel- and CT-based models at the
third generation show a deposition of about 4 and  respectively while that
predicted by Martonen is higher ( ).












Regional deposition fractions (in ) of the Weibel-based models for a flow rate of
30 L/min.
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
Weibel healthy 17.98 2.35 2.2 1.24 2.7
Weibel tracheal stent 22.17 4.21 3.37 1.74 2.18
Weibel bronchial stent 18.2 1.51 4.54 3.96 2.94
Weibel Y stent 20.03 3.26 5.24 1.66 5.03
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
Weibel healthy 17.53 2.04 1.99 1.275 2.84
Weibel tracheal stent 19.8 3.98 3.36 1.01 2.12
Weibel bronchial stent 16.2 3.64 4.52 1.59 3.21
Weibel Y stent 17.93 3.26 3.96 2 4.56
In the Fig. 4, the comparison between the healthy and the three stented airways
is shown. The values of the histograms are summarized in the Tables 3 and 4.
As expected, due to the inertial impaction, the deposition tends to decrease for
decreasing particle diameter.23,24 From the Fig. 4 it is also visible that the
region more affected by the deposition in the presented models, independently
of the inspiratory flow rate and of the particle diameter, is the trachea.
Furthermore, the histograms show that the presence of a prosthesis, that is
technically equivalent to a slight airways constriction, considerably increases
the particle deposition in other regions, as the first generation and the carina.
As obvious, the tracheal stent significantly impacts the particle deposition on
the first generation i.e. at the trachea. The related histogram depicted in the
Fig. 4 highlights that the highest deposition corresponds always to this
prosthesis at the trachea independently of the breathing regime and of the
particle diameter. Its maximal value ( ) is reached at flow rate 30 L/min
with particle diameter m. As visible, in the first generation an
increase of the flow promotes an increase in the deposition fraction. However,
this effect is especially enhanced only for the trachea. The latter, independently
on the used device, shows deposition fractions in the range of about 16–19% for
flow rates of 15 L/min and of about 18–22% for flow rates of 30 L/min. This






generations and depends on the device (the smallest for the bronchial stent, the
highest for the tracheal stent) respect to the healthy models. The deposition
tends to decrease for increasing respiratory flow in the generations 1 and 2
respect to the trachea. However, significant increases in these generations are
presented by the stented models respect to the healthy case. The largest increase
can be found for the bronchial and the Y-stent, which first generation is
constricted by the presence of the prostheses. The increase in this region is of
about 2 and 3 times respectively respect to that found in the healthy model for
inspiratory flow of 30 L/min. In these generations, the deposition looks slightly
more homogeneous among models, independently of the particle diameter, even
the presence of the prosthesis tends to promote an increase of the deposition at
the first generation for the tracheal stent, at the first bifurcation (about ), at
the second generation for the bronchial stent (about ) and at the second
generation and second bifurcation for the Y-stent (about 4 and  respectively).
Table 4
Regional deposition fractions (in ) of the Weibel-based models for a flow rate of
15 L/min.
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
Weibel healthy 15.9 2.85 3.42 1.4 2.07
Weibel tracheal stent 20.6 3.25 3.35 1.61 1.875
Weibel bronchial stent 15.54 3.32 4.29 3.3 2.85
Weibel Y stent 19.63 2.61 4.07 1.6 4.28
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
Weibel healthy 14.82 2.94 3.03 1.37 2
Weibel tracheal stent 19.2 3.61 3.16 1.55 1.77
Weibel bronchial stent 18.7 3.5 1.56 1.27 2.92
Weibel Y stent 18.8 2.9 4.94 1.56 3.56
This tendency slightly reduces for flow rate of 15 L/min but the main
tendencies are still valid. In the trachea, the presence of the device has an
important influence. Again the stents promote important increases in the second
bifurcation. In this generation, an increases of about a factor 2 can be seen







promote the highest deposition ( ). Finally, while at the first bifurcation
the deposition seems more homogeneous and the highest deposition is
suggested by the bronchial stent at 30 L/min for m (about ), in
the second bifurcation, the Y-stent promotes the highest deposition
independently on the particle diameter and on the breathing conditions with
values that range from about 3.5 to .
CT-Based Model
Table 5
Regional deposition fractions (in ) of the CT-based models for a flow rate of
60 L/min.
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
CT-based healthy 12.37 3.96 6.74 1.95 1.76
CT-based tracheal stent 19.4 7.73 3.85 6.26 3.45
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
CT-based healthy 9.27 2.98 6.98 2 2
CT-based tracheal stent 16.76 6.8 3.95 6.06 3.51
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
CT-based healthy 5.6 2.07 4.76 0.94 1.99
CT-based tracheal stent 12.34 7.65 4.065 6.24 3.32
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
CT-based healthy 2.7 4 4.72 1.89 2.16
CT-based tracheal stent 8.3 7.33 3.79 6.43 3.47
Table 6
Regional deposition fractions (in ) of the CT-based models for a flow rate of
30 L/min.
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
CT-based healthy 13.6 3.75 6.72 1.8 1.75
CT-based tracheal stent 28.6 5.95 3.2 5.24 2.63
4.94%









m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
CT-based healthy 12.98 3.67 6.7 1.68 1.98
CT-based tracheal stent 20.18 5.7 2.92 5.01 2.56
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
CT-based healthy 10.29 1.725 1.84 1.3 1.01
CT-based tracheal stent 17.72 3.83 3.283 5.15 1.83
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
CT-based healthy 3.8 3.78 6.5 1.72 1.74
CT-based tracheal stent 10.2 6.12 3 5.5 2.82
Table 7
Regional deposition fractions (in ) of the CT-based models for a flow rate of
15 L/min.
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
CT-based healthy 13.7 3.23 5.94 1.67 1.6
CT-based tracheal stent 19.42 4.95 2.07 4.27 2.03
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
CT-based healthy 7 4 6 3.75 2.84
CT-based tracheal stent 16.63 5.5 2.74 5.1 2.21
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
CT-based healthy 6.24 1.35 2.54 1.84 1.74
CT-based tracheal stent 14.74 4.28 3.07 1.26 2.2
m GEN 0 GEN 1 GEN 2 BIF 1 BIF 2
CT-based healthy 4.3 2.14 1.3 1.55 1.55
CT-based tracheal stent 9.08 4.64 2.23 4.05 2.33
In the Fig. 5, the comparison between the healthy and the stented airways is
shown for flow rates of 60 L/min (Figs. 5a–5d), 30 L/min (Figs. 5e–5h) and









Tables 5, 6 and 7. A qualitative comparison with the Weibel models shows that
the patient specific geometries suggest an increase of the deposition. This is
expected, because the real geometries provide curvatures and tortuosities that
the Weibel models cannot offer. Comparing the CT-based models, an important
increase of particle deposition is visible in the trachea, in the presence of the
prosthesis and independently of the breathing conditions and of the particle
dimension. Its maximal value is ,  and  for flow rates of
60 L/min, 30 L/min and 15 L/min respectively, with particle diameter 
m. This increase is more enhanced at normal breathing conditions
(compare Figs. 5e–5h with Figs. 5a–5d and Figs. 5i–5l). However, a decrease of
deposition can be clearly seen for small particle sizes. In fact, for m,
the maximal values reduced to 8.3, 10.2 and  for flow rates of 60 L/min,
30 L/min and 15 L/min respectively. Obviously, the tracheal stent impacts the
particle deposition especially at the trachea while its increase in the successive
generations looks more limited, as the values are considerably less that .
However, the tendency found with the Weibel models are visible also for the
CT-based models. Important increments in deposition fractions are reported by
the patient specific models at the first bifurcation. There, the tracheal stent
provides systematically higher depositions respect to the healthy case. Its
maximal values ranges from 4 to over  while the maximal deposition for the
healthy case is  (found at light breathing conditions). This tendency can
also be found at the first generation, independently of the flow rates and of the
particle size. In these regions, the deposition in the presence of the prosthesis is
always from 2 to 3 times higher than that of the healthy patient. This ranges
from about 4 to  for the tracheal stent and from about 2 to  for the
healthy case.
Comparison of the Total Deposition Fractions Within
Stented and Unstented Models
The Fig. 6 depicts the total deposition fraction for different flow rates and
different particle sizes along the healthy and the stented airways for both Weibel
and CT models. As it can be seen in this Figure, the deposition increases for
increasing particle diameter, as found by other authors,14,23 because of the
increase of impaction. The Figure clearly shows that, within the Weibel models,
the highest total deposition is promoted by the Y-stent independently of the
flow rate, for particle diameter of 10 µm (35.2 and 32.2%). This means that the
device impacts not only the regions near its location but also downstream the
lower generations. This stent promotes in fact a high deposition at the second
19.4% 28.6% 19.42%
= 15 "!{p}







generation in all the simulated cases (see also Fig. 4). This result is independent
of the flow rate and of the particle diameter. For a flow rate of 15 L/min, the
total deposition is also the highest for the Y stent for  ( ).
However, the tendency for the Weibel models is markedly clear, as the second
highest deposition is always promoted by the tracheal stent and the third one by
the bronchial stent, independently on the inspiratory flow rate. In general, an
increase of the flow tends to increase the relative differences of the total particle
depositions between stented models (compare Figs. 6a and 6b).
In the CT-based healthy and stented airways (Figs. 6c and 6d respectively), it is
visible a marked increase of deposition promoted by the prosthesis (Figs. 6c and
6d,  vs. ) for 30 L/min and particle diameter m.
The increase can be seen for all the flow rates and particle diameters, by
comparing healthy and stented models in the Figs. 6c and 6d. The Figure
depicts an increase of deposition for increasing particle diameters even for a
flow rate of 30 L/min and 15 L/min, the total depositions for particles of 
m are slightly higher than that of m (  vs. 
and  vs. ). Nevertheless, in the literature it has been demonstrated
in fact that for particle diameters smaller than m, the deposition tend to
considerably increase.14 Of course, the deposition for particle of m is much
smaller that that of 10 or m diameters, independently of the flow rate.
Spatial Distribution of the Particle Deposition
Deposition patterns, that illustrate the interaction between the particle and the
airways and stent wall, can be represented by means of the accretion ratio of the
software Ansys Fluent and they give an idea of the locations where the particles
tend to deposit and concentrate in dependence on the particle diameter and flow
rate. This variable represents the particle mass flow rate divided by the particle
impacted face area and it is computed as30:
where N is the number of particles,  is the area of the cell face at the
wall, and  is the mass flow rate of the particles. Since the highest
deposition fraction has been systematically assessed in the CT-based models
respect to the Weibel-based model, which computations have been mainly
provided as a proof of concept, the spatial distribution is represented for the CT-
= 10  "!{p} 32.2%
45.62% 27.615% = 15 "!{p}











geometries first for a fixed flow rate of 15 L/min as a function of the particle
size (Fig. 7) and then for a fixed particle size of m as a function of the flow
rate (Fig. 8).
The Fig. 7 shows the increase of particle deposition due to the presence of the
prosthesis confirming the results observed by means of the histograms (Fig. 5).
As visible, the stented airways are significantly affected by the turbulent
dispersion respect to the healthy airways. A marked deposition is visible at the
trachea inlet for the airways after prosthesis insertion. This is mainly caused by
turbulent fluctuations and high tracheal curvature (see Figs. 7e–7h) respect to
the healthy geometry. The blockage effect of the prosthesis promotes a
considerable redistribution of the locations where the particles deposit.
Significant particle concentrations can be found in the region around the
prostheses, especially its extremities, as shown in the Figs. 7e–7h) respect to
Figs. 7a–7d. The latter drastically increase for increasing particle diameter. In
general, for both models it can be seen that an increase of the particle size
promotes an increase of deposition for both healthy and stented models and that
the increase is more marked for the stented geometries.
The Fig. 8 shows that independently of the flow rate, a marked increase of
deposition is promoted by the stented respect to the unstented geometry.
Furthermore, in the regions near the stent is visible a progressive increase of
deposition (compare Figs. 8a–8c). The superior extremity of the device, that is
orthogonal to the stent axis, is affected by an important deposition as seen also
before for increasing particle diameter at a fixed flow rate. This location has
been found to promote mucous plugging, obstruction and tissue irritation8 so
that the presence of drug overdoses may enhance or add negative effect of the
presence of the stent. Additionally, a massive increase of deposition is also
depicted at the first bifurcation and in the second generation for the stented
model. The proximal region of the trachea in the presence of the stent is
subjected by a high deposition. This is caused firstly by the airflow that enters
skewed the trachea but also by the presence of the device and the promoted
blockage effect.
Discussion
The goal of this work is oriented to the investigation of the particle transport
and deposition in healthy and stented airways for different flow rates and
particle sizes. Special attention has been given to patients that underwent
10 "
prosthesis implantation because of the related lack of knowledge. It is known
that these devices are prone to obstruct and promote inflammations and other
tissue reactions among others negative effects.8,7 Therefore, it is clear that
local concentration of toxic particles inhaled in the environment or overdoses of
aerosol or other drugs may enhance the aforementioned side effects and further
knowledge is necessary for improving eventual therapies and the overall clinical
outcomes. In this sense, the prediction of particle deposition in the stented
airways regions may be necessary for improving the way of life of the patients.
The present work provides a first analysis of particle deposition and transport in
stented airways. However, the understanding of the particle deposition within
the airways after prosthesis implantation may have different applications as, for
example, the improvement of aerosol drug delivery therapies and it may also
help reducing in the future the re-interventions after prosthesis placing as well
as limiting the number of prosthesis side effects. As an example, a successful
drug-aerosol delivery should provide maximum deposition of suitable
therapeutic particles in specific sites of interest, which are related to the
disease. Also, in the aerosol therapies, the potential negative effects in case of
drug overdoses should be minimized.14 The presented results show a local
drastic increase of the particle deposition in the stented trachea. The deposition
increases in fact in this region respect to the healthy case, as demonstrated by
the Weibel-based models. Additionally, the stented regions of the airways, i.e.
the first generation and the carina, are also affected by an increased deposition.
The findings highlight a particular impact of the Y stent among the considered
devices and the trachea seems the place where the highest total deposition
occurs. At the same time, in the CT-models, the tracheal stent promotes a
massive increase of deposition. These results are especially relevant thinking
that they are independent of the breathing conditions and of the particle size.
The diameter reduction imposed by the devices promotes a block effect similar
to an obstruction.2,30 The deposition of micro particle occurs in fact mainly by
impaction, and this includes primary and especially secondary airflow structures
that convect inhaled particles to the airway walls.14 The latter may have a
negative impact on the tissue reaction that is one of the main problem of a
silicone stent. In particular, also independently on the particle size, the
presented results show that a considerable increase of deposition is promoted by
the presence of the prostheses respect to the healthy airways. Moreover, this
result is independent on the particle diameter, as also for small particles the
prosthesis tends to allow higher depositions for the aforementioned reasons. As
conclusion, these patients are inherently prone to particle deposition in the
stented regions and this particle may have different nature such as those coming
from aerosol therapies or those inhaled during the day life. These could be
micro or nanoparticles . However, the nanoparticles may not deposit in the first
generations,14 where the prosthesis is normally located. Thus, the analysis has
been conducted on micro particles that due to their bigger dimensions tend to
deposit also in the first generations. An increase of the distribution of deposited
particles for these patients may contribute to the development of a different
toxicity effect in the regions near the device where the deposition can
concentrate and hence interact with the tissues. The latter may finally result in
absorption and transport of toxic substances into the tissue, blood and the whole
body yet enhancing the possibility of inflammation and further obstructions
near the prosthesis and even other disorders.11
The limitations of this work regard the consideration of a limited number of
bifurcations, the placement of the bronchial and Ystent only in the healthy
Weibel models, the truncation of the model after the larynx and the absence of a
direct validation with experiments among others. Additionally, the presented
simulations are limited to the assumption of steady state flow conditions thus
neglecting any transient effects. For this reason, even the proposed analysis may
help improving clinical drug-aerosol targeting and understanding deposition of
micro particles for patients that need surgical insertion of an airway prosthesis,
the results that can be extrapolated must be taken with careful and they can be
used mainly as indication for further experimental and numerical studies.
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